Here's Why Senseonics Stock Skyrocketed Today
Shares of Senseonics Holdings (NYSEMKT: SENS) soared 43% on Friday after the medical technology company announced promising clinical trial results from a study of its implantable continuous glucose monitoring (CGM) system.
A study designed to evaluate the Eversense CGM system in diabetes patients over a 180-day period demonstrated that the confirmed hypoglycemic-alert detection rate was 93% for the system's primary sensor and 94% for its secondary sensor.
Senseonics Holdings' stock price surged on Friday. Image source: Getty Images.
Source Fool.com
